JP2000506864A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506864A5
JP2000506864A5 JP1997532749A JP53274997A JP2000506864A5 JP 2000506864 A5 JP2000506864 A5 JP 2000506864A5 JP 1997532749 A JP1997532749 A JP 1997532749A JP 53274997 A JP53274997 A JP 53274997A JP 2000506864 A5 JP2000506864 A5 JP 2000506864A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997532749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506864A (ja
Filing date
Publication date
Priority claimed from US08/614,935 external-priority patent/US5804201A/en
Application filed filed Critical
Publication of JP2000506864A publication Critical patent/JP2000506864A/ja
Publication of JP2000506864A5 publication Critical patent/JP2000506864A5/ja
Ceased legal-status Critical Current

Links

JP9532749A 1996-03-11 1997-03-11 スズメバチ抗原5の免疫調節 Ceased JP2000506864A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/614,935 US5804201A (en) 1996-03-11 1996-03-11 Immunomodulatory peptides of vespid antigen 5
US08/614,935 1996-03-11
PCT/US1997/003753 WO1997033910A1 (en) 1996-03-11 1997-03-11 Immunomodulatory peptides of vespid antigen 5

Publications (2)

Publication Number Publication Date
JP2000506864A JP2000506864A (ja) 2000-06-06
JP2000506864A5 true JP2000506864A5 (enExample) 2004-12-02

Family

ID=24463320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9532749A Ceased JP2000506864A (ja) 1996-03-11 1997-03-11 スズメバチ抗原5の免疫調節

Country Status (6)

Country Link
US (2) US5804201A (enExample)
EP (1) EP0954530A1 (enExample)
JP (1) JP2000506864A (enExample)
AU (1) AU724333B2 (enExample)
CA (1) CA2248537A1 (enExample)
WO (1) WO1997033910A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
DE69733343D1 (de) 1996-03-21 2005-06-30 Circassia Ltd Kryptische peptide und verfahren zu ihrer identifizierung
JP2002500198A (ja) * 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
ATE408690T1 (de) * 1998-03-16 2008-10-15 Alk Abello As Mutiertes rekombinantes allergen
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
WO2000054803A2 (en) * 1999-03-16 2000-09-21 Panacea Pharmaceuticals, Llc Immunostimulatory nucleic acids and antigens
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
DE19957904A1 (de) * 1999-12-01 2001-06-07 Merck Patent Gmbh Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung
WO2001083761A1 (en) * 2000-04-28 2001-11-08 Novozymes A/S Laccase mutants
US6773695B2 (en) 2000-10-05 2004-08-10 Mannkind Corporation Modulation of allergic response
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US20030039660A1 (en) 2001-03-02 2003-02-27 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
CN1639571B (zh) * 2002-02-26 2010-05-26 金克克国际有限公司 将蛋白质相对免疫原性进行分级的基于群体的评估方法和手段
EP2345421A1 (en) * 2003-06-23 2011-07-20 Biotech Tools S.A. Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
DE10355838A1 (de) * 2003-11-26 2005-07-07 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von Phospholipase A2
CN100475840C (zh) * 2005-02-23 2009-04-08 中国科学院昆明动物研究所 胡蜂抗菌肽及其制备方法和应用
CN100374152C (zh) 2005-12-23 2008-03-12 中国农业大学 一种过敏性反应抑制剂
AU2010206854A1 (en) * 2009-01-20 2011-08-04 Myelin Repair Foundation, Inc. Compositions and methods for induction of antigen-specific tolerance
US9492505B2 (en) 2009-01-21 2016-11-15 University Of Florida Research Foundation, Inc. Satiation peptide administration
CA2817755C (en) 2010-11-12 2021-07-06 Rachael Terry Modified immune-modulating particles
JP6557140B2 (ja) 2012-06-21 2019-08-07 ノースウェスタン ユニバーシティ ペプチドコンジュゲート粒子
KR20250076678A (ko) 2013-03-13 2025-05-29 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. 염증 치료용 면역-변형된 입자
EP3650047A1 (en) 2013-08-13 2020-05-13 Northwestern University Peptide conjugated particles
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
US11311633B2 (en) 2016-04-16 2022-04-26 University Of Florida Research Foundation, Incorporated Satiation peptides for weight loss and altered taste sensitivity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593877A (en) * 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase

Similar Documents

Publication Publication Date Title
JP2000507118A5 (enExample)
JP2000506264A5 (enExample)
JP2001501104A5 (enExample)
JP2000508796A5 (enExample)
JP2001525822A5 (enExample)
JP2000507766A5 (enExample)
JP2001507951A5 (enExample)
JP2000512094A5 (enExample)
JP2000516596A5 (enExample)
JP2001502652A5 (enExample)
JP2000515124A5 (enExample)
JP2000514202A5 (enExample)
JP2001504965A5 (enExample)
JP2001503739A5 (enExample)
JP2000506650A5 (enExample)
JP2000504992A5 (enExample)
JP2000504267A5 (enExample)
JP2001502046A5 (enExample)
JP2000516223A5 (enExample)
JP2000516698A5 (enExample)
JP2001502073A5 (enExample)
JP2000505356A5 (enExample)
JP2000507574A5 (enExample)
JP2000513959A5 (enExample)
JP2000514468A5 (enExample)